Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Hepatocellular Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00107536
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Ended earlyNCT04541173
What this trial is testing

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Aiwu Ruth He, MD 6
Testing effectiveness (Phase 2)Study completedNCT00044512
What this trial is testing

Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Bayer 137
Testing effectiveness (Phase 2)UnknownNCT00054951
What this trial is testing

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads

Who this might be right for
Hepatocellular Carcinoma
FeRx 30
Testing effectiveness (Phase 2)Looking for participantsNCT07052253
What this trial is testing

A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

Who this might be right for
Hepatocellular Carcinoma (HCC)
Akeso 100
Testing effectiveness (Phase 2)UnknownNCT05444088
What this trial is testing

Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 129
Testing effectiveness (Phase 2)UnknownNCT04834986
What this trial is testing

Tislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma

Who this might be right for
Resectable Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT04050462
What this trial is testing

Nivolumab Combined With BMS-986253 in HCC Patients

Who this might be right for
Hepatocellular Carcinoma
NYU Langone Health 13
Testing effectiveness (Phase 2)Study completedNCT02115373
What this trial is testing

C-Met Second-Line Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Merck KGaA, Darmstadt, Germany 66
Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04172779
What this trial is testing

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, LiverAdvanced Liver Fibrosis
University of Texas Southwestern Medical Center 60
Not applicableStudy completedNCT02774161
What this trial is testing

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

Who this might be right for
CirrhosisEarly Hepatocellular CarcinomaFibrosis+2 more
Stanford University 45
Testing effectiveness (Phase 2)UnknownNCT02561546
What this trial is testing

P53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma

Who this might be right for
HCCDiabetes
Shenzhen SiBiono GeneTech Co.,Ltd 40
Testing effectiveness (Phase 2)Study completedNCT01639352
What this trial is testing

Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Lynn Feun 20
Testing effectiveness (Phase 2)Looking for participantsNCT04803318
What this trial is testing

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05954897
What this trial is testing

Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangdong Provincial People's Hospital 29
Testing effectiveness (Phase 2)UnknownNCT05178043
What this trial is testing

GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHCC
Suzhou Kintor Pharmaceutical Inc, 5
Testing effectiveness (Phase 2)UnknownNCT01825824
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm

Who this might be right for
Hepatocellular Carcinoma
Korea Cancer Center Hospital 54
Testing effectiveness (Phase 2)Study completedNCT02940496
What this trial is testing

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Who this might be right for
BCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular CarcinomaHepatitis C Infection+8 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT01687673
What this trial is testing

Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of California, San Francisco 29
Next Page